Copyright Reports & Markets. All rights reserved.

Global Anti-Cancer Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Anti-Cancer Drug

      • 1.1 Definition of Anti-Cancer Drug
      • 1.2 Anti-Cancer Drug Segment by Type
        • 1.2.1 Global Anti-Cancer Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Avastin
        • 1.2.3 Rituxan
        • 1.2.4 Herceptin
        • 1.2.5 Alimta
      • 1.3 Anti-Cancer Drug Segment by Applications
        • 1.3.1 Global Anti-Cancer Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Home Care
      • 1.4 Global Anti-Cancer Drug Overall Market
        • 1.4.1 Global Anti-Cancer Drug Revenue (2014-2025)
        • 1.4.2 Global Anti-Cancer Drug Production (2014-2025)
        • 1.4.3 North America Anti-Cancer Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Anti-Cancer Drug Status and Prospect (2014-2025)
        • 1.4.5 China Anti-Cancer Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Anti-Cancer Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Anti-Cancer Drug Status and Prospect (2014-2025)
        • 1.4.8 India Anti-Cancer Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Anti-Cancer Drug
      • 2.3 Manufacturing Process Analysis of Anti-Cancer Drug
      • 2.4 Industry Chain Structure of Anti-Cancer Drug

      3 Development and Manufacturing Plants Analysis of Anti-Cancer Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Anti-Cancer Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Anti-Cancer Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Anti-Cancer Drug Production and Capacity Analysis
      • 4.2 Anti-Cancer Drug Revenue Analysis
      • 4.3 Anti-Cancer Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Anti-Cancer Drug Regional Market Analysis

      • 5.1 Anti-Cancer Drug Production by Regions
        • 5.1.1 Global Anti-Cancer Drug Production by Regions
        • 5.1.2 Global Anti-Cancer Drug Revenue by Regions
      • 5.2 Anti-Cancer Drug Consumption by Regions
      • 5.3 North America Anti-Cancer Drug Market Analysis
        • 5.3.1 North America Anti-Cancer Drug Production
        • 5.3.2 North America Anti-Cancer Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Anti-Cancer Drug Import and Export
      • 5.4 Europe Anti-Cancer Drug Market Analysis
        • 5.4.1 Europe Anti-Cancer Drug Production
        • 5.4.2 Europe Anti-Cancer Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Anti-Cancer Drug Import and Export
      • 5.5 China Anti-Cancer Drug Market Analysis
        • 5.5.1 China Anti-Cancer Drug Production
        • 5.5.2 China Anti-Cancer Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Anti-Cancer Drug Import and Export
      • 5.6 Japan Anti-Cancer Drug Market Analysis
        • 5.6.1 Japan Anti-Cancer Drug Production
        • 5.6.2 Japan Anti-Cancer Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Anti-Cancer Drug Import and Export
      • 5.7 Southeast Asia Anti-Cancer Drug Market Analysis
        • 5.7.1 Southeast Asia Anti-Cancer Drug Production
        • 5.7.2 Southeast Asia Anti-Cancer Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Anti-Cancer Drug Import and Export
      • 5.8 India Anti-Cancer Drug Market Analysis
        • 5.8.1 India Anti-Cancer Drug Production
        • 5.8.2 India Anti-Cancer Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Anti-Cancer Drug Import and Export

      6 Anti-Cancer Drug Segment Market Analysis (by Type)

      • 6.1 Global Anti-Cancer Drug Production by Type
      • 6.2 Global Anti-Cancer Drug Revenue by Type
      • 6.3 Anti-Cancer Drug Price by Type

      7 Anti-Cancer Drug Segment Market Analysis (by Application)

      • 7.1 Global Anti-Cancer Drug Consumption by Application
      • 7.2 Global Anti-Cancer Drug Consumption Market Share by Application (2014-2019)

      8 Anti-Cancer Drug Major Manufacturers Analysis

      • 8.1 Merck
        • 8.1.1 Merck Anti-Cancer Drug Production Sites and Area Served
        • 8.1.2 Merck Product Introduction, Application and Specification
        • 8.1.3 Merck Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bristol-Myers Squibb
        • 8.2.1 Bristol-Myers Squibb Anti-Cancer Drug Production Sites and Area Served
        • 8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.2.3 Bristol-Myers Squibb Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bayer
        • 8.3.1 Bayer Anti-Cancer Drug Production Sites and Area Served
        • 8.3.2 Bayer Product Introduction, Application and Specification
        • 8.3.3 Bayer Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 GlaxoSmithKline
        • 8.4.1 GlaxoSmithKline Anti-Cancer Drug Production Sites and Area Served
        • 8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.4.3 GlaxoSmithKline Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Novartis
        • 8.5.1 Novartis Anti-Cancer Drug Production Sites and Area Served
        • 8.5.2 Novartis Product Introduction, Application and Specification
        • 8.5.3 Novartis Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sanofi
        • 8.6.1 Sanofi Anti-Cancer Drug Production Sites and Area Served
        • 8.6.2 Sanofi Product Introduction, Application and Specification
        • 8.6.3 Sanofi Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Pfizer
        • 8.7.1 Pfizer Anti-Cancer Drug Production Sites and Area Served
        • 8.7.2 Pfizer Product Introduction, Application and Specification
        • 8.7.3 Pfizer Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Amgen
        • 8.8.1 Amgen Anti-Cancer Drug Production Sites and Area Served
        • 8.8.2 Amgen Product Introduction, Application and Specification
        • 8.8.3 Amgen Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Celgene Corporation
        • 8.9.1 Celgene Corporation Anti-Cancer Drug Production Sites and Area Served
        • 8.9.2 Celgene Corporation Product Introduction, Application and Specification
        • 8.9.3 Celgene Corporation Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Ariad Pharmaceuticals
        • 8.10.1 Ariad Pharmaceuticals Anti-Cancer Drug Production Sites and Area Served
        • 8.10.2 Ariad Pharmaceuticals Product Introduction, Application and Specification
        • 8.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Eli Lilly
      • 8.12 Hoffmann-La Roche Ltd.
      • 8.13 AstraZeneca
      • 8.14 Boehringer Ingelheim GmbH
      • 8.15 Teva Pharmaceuticals

      9 Development Trend of Analysis of Anti-Cancer Drug Market

      • 9.1 Global Anti-Cancer Drug Market Trend Analysis
        • 9.1.1 Global Anti-Cancer Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Anti-Cancer Drug Regional Market Trend
        • 9.2.1 North America Anti-Cancer Drug Forecast 2019-2025
        • 9.2.2 Europe Anti-Cancer Drug Forecast 2019-2025
        • 9.2.3 China Anti-Cancer Drug Forecast 2019-2025
        • 9.2.4 Japan Anti-Cancer Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Anti-Cancer Drug Forecast 2019-2025
        • 9.2.6 India Anti-Cancer Drug Forecast 2019-2025
      • 9.3 Anti-Cancer Drug Market Trend (Product Type)
      • 9.4 Anti-Cancer Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Anti-Cancer Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
        China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
        Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.

        The global Anti-Cancer Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Anti-Cancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Cancer Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Cancer Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Anti-Cancer Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Merck
        Bristol-Myers Squibb
        Bayer
        GlaxoSmithKline
        Novartis
        Sanofi
        Pfizer
        Amgen
        Celgene Corporation
        Ariad Pharmaceuticals
        Eli Lilly
        Hoffmann-La Roche Ltd.
        AstraZeneca
        Boehringer Ingelheim GmbH
        Teva Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Avastin
        Rituxan
        Herceptin
        Alimta

        Segment by Application
        Hospital
        Clinic
        Home Care

        Buy now